Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/301080 stock hub

SHE/301080 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/301080is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.7B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/301080

In the news

Latest news · SHE/301080

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E29.4

P25 17.1P50 24.2P75 37.8

Trailing P/E44.3

P25 23.5P50 41.3P75 83.2

ROE6.4

P25 -0.9P50 4.1P75 8.8

ROIC9.1

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/301080 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

218

Groups with data

Currency

CNY

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	869
Employees Change	93%
Employees Change Percent	11.98
Enterprise value	CNY 6.5B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	CNY 7.7B
Price	CNY 45.99
Price currency	CNY
Rev Per Employee	1,020,958.93x
Sector	Healthcare
Sic	2836
Symbol	she/301080
Website	https://www.acrobiosystems.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.23%
EV Earnings	37.7x
EV/EBIT	48.38x
EV/EBITDA	31.88x
EV/FCF	45.85x
EV/Sales	7.28x
FCF yield	1.83%
Forward P/E	29.44x
P/B ratio	2.85x
P/E ratio	44.26x
P/S ratio	8.67x
PE Ratio3 Y	46.31x
PE Ratio5 Y	51.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.04%
EBITDA Margin	20.37%
FCF margin	15.87%
Gross margin	83.85%
Gross Profit	CNY 743.9M
Gross Profit Growth	28.24%
Gross Profit Growth Q	26.32%
Gross Profit Growth3 Y	19.96%
Gross Profit Growth5 Y	23.11%
Net Income	CNY 171.2M
Net Income Growth	28.05%
Net Income Growth Q	13.99%
Net Income Growth3 Y	-4.28%
Net Income Growth5 Y	4.82%
Pretax Margin	19.76%
Profit Margin	19.3%
Profit Per Employee	CNY 197,061
ROA	2.87
Roa5y	3.23
ROCE	4.67
ROE	6.42
Roe5y	7.5
ROIC	9.07
Roic5y	29.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	35.49%
Cagr3y	0.74%
EPS Growth	32.36
EPS Growth Q	21.25
EPS Growth3 Y	-3.66
EPS Growth5 Y	-0.62
FCF Growth Q	-54.61%
FCF Growth5 Y	13%
OCF Growth	320.75%
OCF Growth Q	19.37%
OCF Growth3 Y	20.08%
OCF Growth5 Y	29.82%
Revenue Growth	29.42x
Revenue Growth Q	26.33x
Revenue Growth3 Y	21.31x
Revenue Growth5 Y	25.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.3
Assets	CNY 3B
Cash	CNY 1.3B
Current Assets	CNY 1.7B
Current Liabilities	CNY 130.7M
Debt	CNY 82.6M
Debt EBITDA	CNY 0.41
Debt Equity	CNY 0.03
Debt FCF	CNY 0.59
Equity	CNY 2.7B
Interest Coverage	135.5
Liabilities	CNY 285.2M
Long Term Assets	CNY 1.2B
Long Term Liabilities	CNY 154.6M
Net Cash	CNY 1.2B
Net Cash By Market Cap	CNY 16.03
Net Cash Growth	-28.18%
Net Debt EBITDA	CNY -6.82
Net Debt Equity	CNY -0.46
Net Debt FCF	CNY -8.75
Tangible Book Value	CNY 2.7B
Tangible Book Value Per Share	CNY 15.96
WACC	8.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	13.3
Inventory Turnover	0.59
Net Working Capital	CNY 310.6M
Quick ratio	10.97
Working Capital	CNY 1.6B
Working Capital Turnover	CNY 0.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.26%
Dividend Growth	-4.44%
Dividend Growth Years	0%
Dividend per share	CNY 0.6
Dividend Years	4
Dividend Yield	1.3%
Last Dividend	CNY 0.4
Payout Ratio	28.02%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	35.46%
200-day SMA	54.18
3Y total return	2.25%
50-day SMA	45.49
50-day SMA vs 200-day SMA	50under200
All Time High	122.2
All Time High Change	-62.36%
All Time High Date	2021-11-30
All Time Low	22.36
All Time Low Change	105.71%
All Time Low Date	2024-09-18
ATR	1.75
Beta	0.76
Beta1y	0.76
Beta2y	0.94
Ch YTD	-14.83
High	46.97
High52	71.49
High52 Date	2026-01-26
High52ch	-35.67%
Low	44.47
Low52	33.14
Low52 Date	2025-05-12
Low52ch	38.76%
Ma50ch	1.09%
Price vs 200-day SMA	-15.12%
RSI	49.08
RSI Monthly	48.46
RSI Weekly	43.14
Sharpe ratio	0.93x
Sortino ratio	1.7
Total Return	4.57%
Tr YTD	-14.83
Tr1m	1.3%
Tr1w	3.05%
Tr3m	-7.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 133.4M
Operating Income Growth	73.24
Operating Income Growth Q	35.23
Operating Income Growth3 Y	7.95
Operating Income Growth5 Y	-3.75
Operating margin	15.04

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	89,926,595%
Net Borrowing	-19,471,148
Shares Insiders	36.89%
Shares Institutions	17.82%
Shares Out	167,177,695
Shares Qo Q	-0.32%
Shares Yo Y	-3.26%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 140.8M
Average Volume	4,227,720.65x
Bv Per Share	16.16
CAPEX	CNY -221.4M
Ch1m	1.3
Ch1w	3.05
Ch1y	34.67
Ch3m	-7.41
Ch3y	-3.31
Ch6m	-23.09
Change	2.36%
Change From Open	2.31
Close	44.93
Days Gap	0.04
Depreciation Amortization	47,288,528
Dollar Volume	227,554,886.8
Earnings Date	2026-04-21
EBIT	CNY 133.4M
EBITDA	CNY 180.7M
EPS	CNY 1.04
F Score	6
FCF	CNY 140.8M
FCF EV Yield	2.18x
FCF Per Share	CNY 0.84
Financing CF	-109,311,590
Fiscal Year End	December
Founded	2,010
Graham Number	19.43793
Graham Upside	-57.73
Income Tax	CNY 4.5M
Investing CF	-112,764,004
Is Primary Listing	1
Last Earnings Date	2026-04-21
Last Report Date	2026-03-31
Last Split Date	2025-07-11
Last Split Type	Forward
Lynch Fair Value	CNY 5.2
Lynch Upside	-88.7
Ma150	53.71
Ma150ch	-14.37%
Ma20	46.98
Ma20ch	-2.11%
Net CF	133,569,718
Next Earnings Date	2026-08-21
Open	44.95
P FCF Ratio	54.6
P OCF Ratio	21.23
Payment Date	2025-07-11
Position In Range	60.8
Ppne	561,217,765
Price Date	2026-05-08
Price EBITDA	CNY 42.54
Ptbv Ratio	2.88
Relative Volume	1.17x
Revenue	887,213,306x
Tax By Revenue	0.51x
Tax Rate	2.58%
Tr6m	-23.09%
Volume	4,947,921
Z Score	19.07

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/301080 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.3%

$0.60 annual per share

Payout ratio

+28.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+4.6%

Dividend yield + buyback yield combined

Performance

SHE/301080 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/301080?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.8%

Share of float held by funds and institutions

Insider ownership

+36.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-3.3%

Negative means the company is buying back shares.

Technical

SHE/301080 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.1

Neutral momentum band

Price vs 200-day MA

-15.1%

50/200-day relationship not available

Beta (5Y)

0.76

Less volatile than the market

Sharpe ratio

0.93

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/301080

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/301080 stock rating?

she/301080 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/301080 analysis?

The full report lives at /stocks/she/301080/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/301080?

The latest report frames she/301080 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/301080 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.